| Study period | |||||
---|---|---|---|---|---|---|
Enrollment | Baseline | Treatment phase | Follow-up phase | |||
Timepoint | -1 week | 0 weeks | 3 weeks | 6 weeks | 4 weeks | 12 weeks |
Enrollment | ||||||
 Eligibility screen | X |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |
 Medical history | X |  |  |  |  |  |
 Allocation |  | X |  |  |  |  |
Interventions | ||||||
 Acupuncture |  | X | X | X |  |  |
 Sham acupuncture |  | X | X | X |  |  |
Assessments | ||||||
 Primary outcome | ||||||
  BFI-C |  | X | X | X | X | X |
 Secondary outcomes | ||||||
  EORTC QLQ-C30 |  | X |  | X |  |  |
  HAMD |  | X |  | X |  |  |
Others | ||||||
 Adverse events |  | X | X | X |  |  |
 Patients’ satisfaction |  |  |  | X |  |  |
 Success of blinding |  |  |  | X |  |  |